Hours Alice, Toussaint Aullene, De Castelbajac Victoire, Sautter Camille, Borghese Julie, Frank Sophie, Coussy Florence, Laas Enora, Grandal Beatriz, Dumas Elise, Daoud Eric, Guerin Julien, Balezeau Thomas, Feron Jean-Guillaume, Fourchotte Virginie, Kirova Youlia, Lerebours Florence, Pierga Jean-Yves, Guillot Eugénie, Santulli Pietro, Grynberg Michael, Sonigo Charlotte, Reyrat Emmanuel, Soibinet-Oudot Pauline, Reyal Fabien, Hamy Anne-Sophie
Department of Surgery, Institut Curie, University Paris, Paris, France.
Department of Medical Oncology, Institut Curie, University Paris, Paris, France.
Front Oncol. 2021 Sep 28;11:701620. doi: 10.3389/fonc.2021.701620. eCollection 2021.
Female breast cancer (BC) patients exposed to gonadotoxic chemotherapy are at risk of future infertility. There is evidence of disparities in the discussion of fertility preservation for these patients. The aim of the study was to identify factors influencing the discussion of fertility preservation (FP).
We analyzed consecutive BC patients treated by chemotherapy at Institut Curie from 2011-2017 and aged 18-43 years at BC diagnosis. The discussion of FP was classified in a binary manner (discussion/no discussion), based on mentions present in the patient's electronic health record (EHR) before the initiation of chemotherapy. The associations between FP discussion and the characteristics of patients/tumors and healthcare practitioners were investigated by logistic regression analysis.
The median age of the 1357 patients included in the cohort was 38.7 years, and median tumor size was 30.3 mm. The distribution of BC subtypes was as follows: 702 luminal BCs (58%), 241 triple-negative breast cancers (TNBCs) (20%), 193 HER2/HR (16%) and 81 HER2/HR (6%). All patients received chemotherapy in a neoadjuvant (=611, 45%) or adjuvant (= 744, 55%) setting. A discussion of FP was mentioned for 447 patients (33%). Earlier age at diagnosis (discussion: 34.4 years no discussion: 40.5 years), nulliparity (discussion: 62% no discussion: 38%), and year of BC diagnosis were the patient characteristics significantly associated with the mention of FP discussion. Surgeons and female physicians were the most likely to mention FP during the consultation before the initiation of chemotherapy (discussion: 22% and 21%, respectively). The likelihood of FP discussion increased significantly over time, from 15% in 2011 to 45% in 2017. After multivariate analysis, FP discussion was significantly associated with younger age, number of children before BC diagnosis, physicians' gender and physicians' specialty.
FP discussion rates are low and are influenced by patient and physician characteristics. There is therefore room for improvement in the promotion and systematization of FP discussion.
接受性腺毒性化疗的女性乳腺癌(BC)患者面临未来不孕的风险。有证据表明,在为这些患者讨论生育力保存方面存在差异。本研究的目的是确定影响生育力保存(FP)讨论的因素。
我们分析了2011年至2017年在居里研究所接受化疗且在BC诊断时年龄为18至43岁的连续BC患者。根据化疗开始前患者电子健康记录(EHR)中提及的内容,将FP讨论以二元方式分类(讨论/未讨论)。通过逻辑回归分析研究FP讨论与患者/肿瘤特征及医疗保健从业者之间的关联。
该队列中纳入的1357例患者的中位年龄为38.7岁,中位肿瘤大小为30.3毫米。BC亚型分布如下:702例腔面型BC(58%),241例三阴性乳腺癌(TNBC)(20%),193例HER2/HR(16%)和81例HER2/HR(6%)。所有患者均在新辅助(=611例,45%)或辅助(=744例,55%)治疗环境中接受化疗。447例患者(33%)提及了FP讨论。诊断时年龄较小(讨论组:34.4岁,未讨论组:40.5岁)、未生育(讨论组:62%,未讨论组:38%)以及BC诊断年份是与提及FP讨论显著相关的患者特征。外科医生和女医生在化疗开始前的会诊中最有可能提及FP(讨论组分别为22%和21%)。随着时间的推移,FP讨论的可能性显著增加,从2011年的15%增至2017年的45%。多变量分析后,FP讨论与年龄较小、BC诊断前子女数量、医生性别和医生专业显著相关。
FP讨论率较低,且受患者和医生特征的影响。因此,在促进和系统化FP讨论方面仍有改进空间。